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Gram-negative bacteria produce outer membrane vesicles (OMVs) that package and deliver proteins, small molecules, and DNA
to prokaryotic and eukaryotic cells. The molecular details of OMV biogenesis have not been fully elucidated, but peptidoglycan-
associated outer membrane proteins that tether the outer membrane to the underlying peptidoglycan have been shown to be
critical for OMV formation in multiple Enterobacteriaceae. In this study, we demonstrate that the peptidoglycan-associated
outer membrane proteins OprF and OprI, but not OprL, impact production of OMVs by the opportunistic pathogen Pseudomo-
nas aeruginosa. Interestingly, OprF does not appear to be important for tethering the outer membrane to peptidoglycan but in-
stead impacts OMV formation throughmodulation of the levels of the Pseudomonas quinolone signal (PQS), a quorum signal
previously shown by our laboratory to be critical for OMV formation. Thus, the mechanism by which OprF impacts OMV for-
mation is distinct from that for other peptidoglycan-associated outer membrane proteins, including OprI.
Vesiculation is a highly conserved process occurring in all do-mains of life (1–4). Among prokaryotes, vesicle formation has
been reported in both Gram-negative and Gram-positive bacteria
(1, 2, 4, 5). Gram-negative bacteria produce spherical, bilayered
vesicles derived from the outer membrane that range in size from
20 to 500 nm (6–10). Similar to the outer membrane, outer mem-
brane vesicles (OMVs) possess an outer leaflet of lipopolysaccha-
ride (LPS) and an inner leaflet of phospholipid (11–15). OMVs
also contain outer membrane proteins and entrap periplasmic
components as they are released (16–18). OMVs have been found
to be associated with Gram-negative bacteria growing planktoni-
cally and in surface-attached biofilm communities as well as nat-
ural environments (11, 19–21).
Despite their biological importance, the molecular mechanism
of OMV formation has not been fully elucidated, though multiple
factors have been reported to affect the process (13, 22–28) and nu-
merous models encompassing these factors have been proposed (9,
19, 28–31). A primary hurdle to elucidating the mechanism of OMV
formation has been the inability to identify factors that contribute to
OMV production. Using the model opportunistic pathogen Pseu-
domonas aeruginosa, our laboratory demonstrated that the quorum-
sensing signal 2-heptyl-3-hydroxy-4-quinolone (Pseudomonas quin-
olone signal [PQS]) stimulates P. aeruginosa OMV biogenesis (10,
32). Surprisingly, signaling by PQS was not required for OMV for-
mation (10); instead, OMV formation proceeds through direct inter-
action of PQS with the LPS component of the outer membrane (29).
Based on these results, we recently proposed a detailed P. aeruginosa
OMV biogenesis model, dubbed the bilayer-couple model, in which
PQS induces membrane curvature by stably inserting and expanding
the outer leaflet of the outer membrane relative to the inner leaflet
(31), resulting in localized membrane curvature and ultimately vesic-
ulation.
One question regarding the bilayer-couple model that remains
is the role that peptidoglycan-associated outer membrane pro-
teins play in P. aeruginosa OMV biogenesis. Multiple studies in
bacteria other than P. aeruginosa have suggested that OMV for-
mation is localized to regions of the outer membrane not tethered
to the underlying peptidoglycan layer (6, 8, 33). Loss of the pep-
tidoglycan-associated outer membrane protein OmpA, Pal, or
Lpp significantly increases OMV formation inEscherichia coli, Sal-
monella enterica serovar Typhimurium, and Vibrio cholerae (6,
34–37). Homologs of OmpA, Pal, and Lpp exist in P. aeruginosa,
although their involvement in OMV biogenesis is not known (38).
OprF is a 38-kDa OmpA homolog that serves both as a porin and
as a tether that noncovalently links the outer membrane to pepti-
doglycan (39). OprF exists in two conformations: when closed, the
C terminus anchors the outer membrane to the peptidoglycan
layer, and when open, the C terminus inserts into the outer mem-
brane, forming a functional porin (40). OprL is an 18-kDa Pal
homolog that also tethers the outer membrane to peptidoglycan
(41–44). Finally, OprI is an 8-kDa homolog of Braun’s lipoprotein
(Lpp) and is proposed to covalently interact with the peptidogly-
can layer (45), though this interaction has been reported to differ
among P. aeruginosa strains (39, 46). OprI is highly abundant in
the outer membrane (46) and, similar to E. coli Lpp, can exist in a
free and a peptidoglycan-bound form (46).
The goal of this study was to assess the involvement of these
three peptidoglycan-associated outer membrane proteins in P.
aeruginosaOMV biogenesis. Here we demonstrate that deletion of
oprF and oprI induces P. aeruginosa vesiculation through two dis-
tinct mechanisms. The absence of OprF increases OMV produc-
tion via increased PQS production, while loss of OprI presumably
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decreases tethering of the outer membrane to peptidoglycan.
These findings are presented in the context of the membrane bi-
layer-couple model to provide a working model for P. aeruginosa
OMV biogenesis.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions.Bacterial strains and
plasmids are listed in Table 1. Escherichia coli strains were grown in Luria-
Bertani (LB) broth or tryptic soy broth (TSB) with ampicillin (100g/ml)
or tetracycline (10 g/ml), when appropriate. P. aeruginosa strains were
grown in brain heart infusion (BHI) broth with carbenicillin (150g/ml),
gentamicin (50 g/ml), or tetracycline (50 g/ml), when appropriate.
DNA manipulations. DNA manipulations were performed using
standard procedures (52). PCR was performed using an Expand Long
Template PCR system (Roche). A QIAprep spin miniprep kit (Qiagen) or
GeneJET plasmid miniprep kit (Fermentas) was used for plasmid purifi-
cation. Restriction endonucleases and buffers were purchased from New
England BioLabs or Fermentas Life Sciences. A DNeasy tissue kit (Qiagen)
was used to extract chromosomal DNA. DNA sequencing was performed
at the DNA Core Facility at the University of Texas Institute for Cell and
Molecular Biology.
Construction of P. aeruginosa deletion strains. Unmarked deletions
in oprL, oprI, and pqsH were made via allelic exchange as previously de-
scribed (50) with some modifications. Deletion plasmids were con-
structed using the primer pairs listed in Table 2. The two amplicons were
combined using overlap extension PCR and digested using BamHI (for
oprL and oprIdeletions) or EcoRI and XbaI (for pqsHdeletion) and ligated
into pEX18Tc. Each deletion plasmid was transformed into E. coli SM10
and conjugated into P. aeruginosa PA14. For the P. aeruginosa oprF pqsH
double mutant, the pqsH deletion plasmid was conjugated into the oprF
mutant. Mutant selection was performed as previously described (50),
with some modifications. To select the pEX18Tc-oprL, pEX18Tc-oprI,
and pEX18Tc-pqsH transconjugants, conjugations were spread onto LB
plates with 50g/ml tetracycline and 25g/ml nalidixic acid. To select for
the pEX18Tc-pqsH transconjugant in the oprF mutant background, con-
jugations were spread on a morpholinepropanesulfonic acid (MOPS)-
buffered defined medium (25 mM MOPS [pH 7.2], 93 mM NH4Cl, 43
mM NaCl, 3.7 mM KH2PO4, 1 mM MgSO4, 3.5 M FeSO4 · 7H2O)
supplemented with 1.25% agarose, 20 mM succinate, and 20 g/ml
tetracycline. To select for the oprF pqsH double mutant, transconjugants
TABLE 1 Strains and plasmids
Strain or plasmid Description Reference or source
Strains
E. coli
DH5 endA1 hsdR17 supE44 thi-1 recA1 (lacZYA-argF)U169 deoR 80dlacZM15 47
SM10 thi-1 thr leu tonA lacY supE recA::RP4-2-Tc::Mu (Kmr) 48
P. aeruginosa
PA14 Wild type 49
oprL mutant PA14 oprL This study
oprI mutant PA14 oprI This study
oprF mutant PA14 oprF::Mar2XT7 (Gmr) 49
pqsH mutant PA14 pqsH This study
oprF pqsH mutant PA14 oprF::Mar2XT7 pqsH (Gmr) This study
oprI pqsH mutant PA14 oprI pqsH This study
Plasmids
pGEM-T Easy Sequencing vector Promega
pEX18Tc Gene replacement vector (oriT sacB Tcr) 50
pEX18Tc-oprL pEX18Tc containing 1-kb sequences flanking oprL This study
pEX18Tc-oprI pEX18Tc containing 1-kb sequences flanking oprI This study
pEX18Tc-pqsH pEX18Tc containing 1-kb sequences flanking pqsH This study
pEX1.8 Broad-host-range expression vector, IPTG inducible (Apr) 51
pEX1.8-oprF pEX1.8 carrying oprF This study
pEX1.8-oprI pEX1.8 carrying oprI This study
TABLE 2 Primer sequences
Name Sequencea
oprL-flanking regions
oprL-P1 CCGGATCCGAGAAGCTCACCGGTATCAAG
oprL-P2 GTGCTTGGGCATAACGACTTCCATGTAACTC
CTAATGAACCC
oprL-P3 GAAGTCGTTATGCCCAAGCAC
oprL-P4 CAGGATCCGTACTGGGAAATGACCTGCTG
oprI-flanking regions
oprI-P1 5=-CCGGATCCAGGTACTCCAGGTTCAGCCAC
oprI-P2 5=-GTTTTCAACAGGTCGTGAGACCGGTGGA
CATTTCCATAACAGCAATC
oprI-P3 5=-GGTCTCACGACCTGTTGAAAAC-3=
oprI-P4 5=-CCGGATCC AGGTGATCAAGGCCAAGTAC-3=
pqsH-flanking regions
pqsH-P1 5=-CTGAATTCCTTGTCCTGCAGGTCGATATC-3=
pqsH-P2 5=-CATCGCCGAACTCGAAAACAGGATAAGAA
CGGTCATCCGTTGC-3=
pqsH-P3 5=-GCAACGGATGACCGTTCTTATCCTGTTTT
CGAGTTCGGCGATG-3=
pqsH-P4 5=-CTTCTAGAGATTGCTACAGGTAGCGAGG-3=
Complementation
oprF-for 5=-CTAACTGACCATCAAGATGGG-3=
oprF-rev 5=-CCCAAGCTTTTTTCCTTAGAGGCTCA-3=
oprI-for 5=-CGGAATTCGTCCACCTTAAGGGGAAC-3=
oprI--rev 5=-CCCAAGCTTCAGGTCGTGAGACCTAT-3=
a Underlined sequences represent recognition sites for restriction endonucleases.
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were grown overnight in MOPS supplemented with 20 mM succinate and
20 g/ml tetracycline, diluted into antibiotic-free medium, and spread
onto LB plates supplemented with 10% sucrose. Mutants were confirmed
by PCR and sequencing.
Complementation of the P. aeruginosa oprF and oprImutants. oprF
and oprI were PCR amplified from PA14 chromosomal DNA using the
primer pairs indicated in Table 2. The oprF PCR product was cloned into
the pGEM-T Easy vector (Promega) and digested with PstI and HindIII.
The oprIPCR product was purified and digested using EcoRI and HindIII.
Purified digested products were separately ligated into PstI/HindIII- or
EcoRI/HindIII-digested pEX1.8, and the resulting plasmids (pEX1.8-
oprF and pEX1.8-oprI) were verified via DNA sequencing. It should be
noted that the oprI gene amplified and cloned in this study contained 3
base pair differences from the published PA14 genome, resulting in codon
changes H36D, X47E, and K79N. Plasmids were electroporated into the
oprF mutant and oprI mutant (52). Isopropyl--D-1-thiogalactopyrano-
side (IPTG) was added to cultures at 500 M to induce gene expression.
OMV preparation. For OMV preparation, P. aeruginosa overnight
cultures were diluted to an optical density at 600 nm (OD600) of 0.001 to
0.05 in BHI broth. Cells were grown to an OD600 of 2.7 to 3.9 with shaking
at 250 rpm in a 1:10 culture volume/flask volume ratio. When adding
exogenous PQS, synthetic PQS resuspended in 500 l methanol was
added to 25 ml BHI before adding cells, such that the final concentrations
of PQS in the culture were 0.5, 10, 20, and 40 M. OMVs were purified
using methods described previously (13). Briefly, cells were removed by
centrifugation (5,000 g for 15 min), and the resulting supernatant was
filtered through a 0.45-m-pore-size membrane (Whatman PuraDisc 25-
mm-diameter syringe filters, polyethersulfone [PES]). OMVs were pel-
leted from cell-free supernatants using an ultracentrifuge with a Beckman
70Ti rotor at 265,000 g for 1 h and resuspended in MV buffer (50 mM
Tris, 5 mM NaCl, 1 mM MgSO4, pH 7.4).
OMV quantification. OMV production was quantified using a previ-
ously described phospholipid assay of purified vesicles (53, 54) with some
modifications. Purified OMV pellets were extracted with 2 volumes of
chloroform, dried under N2 gas, and resuspended in chloroform (500 l
or 1 ml chloroform). The absorbance was measured at 470 nm and nor-
malized by the OD600 of the extracted culture. To determine the linear
range of detection for the assay, commercially available phosphatidyletha-
nolamine (PE; Fluka Biochemika) was used to generate a standard curve
with concentrations ranging from 7.8 to 250g/ml. Measurements made
below the limit of detection were assigned a value equal to the lowest limit
of the standard curve.
PQS and HHQ extraction and quantification. PQS and HHQ were
extracted from cultures using 2 volumes of acidified ethyl acetate (acidi-
fied with 0.1 ml acetic acid/liter ethyl acetate). The organic phase was
removed and dried under a continuous stream of N2 gas. PQS was quan-
tified using thin-layer chromatography (TLC) (53). For TLC, dried sam-
ples were resuspended in methanol (Optima grade; Fisher), and 5 l was
spotted onto a dried straight-phase phosphate-impregnated TLC plate.
Samples were separated using a 95:5 dichloromethane-methanol mobile
phase. Synthetic PQS standards were used to generate a standard curve.
PQS spots were measured via photography with excitation by long-wave
UV light. HHQ was quantified using high-performance liquid chroma-
tography (HPLC) as previously described (66).
Proteomics. Liquid chromatography-mass spectrometry/mass spec-
trometry (LC-MS/MS) was performed as described previously (55).
Briefly, OMVs were isolated as described above and resuspended in lysis
buffer (25 mM Tris-HCl [pH 7.5], 5 mM dithiothreitol [DTT], 1.0 mM
EDTA, 1 Calbiochem protease inhibitor cocktail [CPICPS]). Fifty mi-
croliters of diluted OMV lysate was incubated at 55°C for 45 min with 50
l of trifluoroethanol (TFE) and 15 mM DTT, followed by incubation
with 55 mM iodoacetamide (IAM) in the dark for 30 min. The sample
volume was adjusted to 1 ml with buffer (50 mM Tris, pH 8.0), followed
by a 1:50 (wt/wt) trypsin digestion for 4.5 h. The reaction was halted by
adding 2% (vol/vol; 20 l) formic acid. The sample was lyophilized, re-
suspended with buffer C (95% H2O, 5% acetonitrile, 0.01% formic acid),
and cleaned using a C18 tip (Thermo Fisher Scientific). The eluted sample
was again lyophilized, resuspended with 120 l buffer C, and filtered
through an Amicon Ultra-0.5 filter (for 12 min at 14,000 g at 4°C). Each
sample was injected 2 times into an LTQ Orbitrap Velos mass spectrom-
eter (Thermo Fisher Scientific), and data were collected in a 0 to 90%
acetonitrile gradient over 5 h. The raw files from LC-MS/MS experiments
are available at http://www.marcottelab.org/index.php/PSEAE_oprF
.2012.
LC-MS/MS raw files were searched against the P. aeruginosa PA14
FIG 1 Growth characteristics of wt P. aeruginosa and the oprI, oprF, and oprL
mutants. Bacteria were grown with shaking (250 rpm) at 37°C in BHI. Repre-
sentative growth curves are shown.
FIG 2 Inactivation of oprF and oprI increases P. aeruginosa OMV production.
(A) Fold change in OMV production by the P. aeruginosa oprF, oprL, and oprI
mutants. Bacteria were grown with shaking (250 rpm) at 37°C to an OD600 of
3.5, and OMVs were quantified by measuring OMV lipid. All lipid measure-
ments were normalized to cell number. For each replicate, the fold change in
OMV production was calculated by dividing mutant lipid levels by wt lipid
levels. The dotted line represents no change in OMV production. Error bars
represent standard errors of the means (n 4). (B) Complementation of the
oprF and oprI mutants. The fold change in OMV production by the oprF and
oprI mutants carrying either vector alone (pEX1.8) or the complementation
plasmids (pEX1.8-oprF or pEX1.8-oprI) is shown. Bacteria were grown
with shaking (250 rpm) at 37°C to an OD600 of 3.5 with 500 M IPTG.
OMVs were quantified and compared to those of wt P. aeruginosa carrying
pEX1.8 as described for panel A. Error bars represent standard errors of the
means (n  4).
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protein sequence database (downloaded from the PseudoCAP database,
23 November 2009 version) (56) with randomly shuffled protein se-
quences as a decoy. Four different search engines, Crux (57), X!Tandem
with k score (58, 59), InsPecT (60), and MS-GFDB (61), were used with
default options. The results were then integrated with the MSblender pro-
gram (55). APEX scores (62, 63) estimating absolute protein abundance
were calculated using the number of peptide-spectrum matches assigned
by MSblender with a false discovery rate with a cutoff of	0.01 and APEX
observability score (Oi values) trained by whole-cell lysate proteomics
data. Protein localization information was also downloaded from Pseudo-
CAP (56). To simplify the localization data, cellular compartments were
prioritized in the following order: outer membrane, extracellular,
periplasmic, cytoplasmic membrane, and cytoplasmic. For example, a
protein annotated as both periplasmic and cytoplasmic would be consid-
ered a periplasmic protein in this analysis. Proteins not localized to one of
these five compartments on the basis of annotation were considered un-
known. All search results and detailed parameters are also available at
http://www.marcottelab.org/index.php/PSEAE_oprF.2012. A summary
of the results is available in Table S1 in the supplemental material.
RESULTS AND DISCUSSION
Several OMV biogenesis models hypothesize that loss of outer
membrane connections to the underlying peptidoglycan is re-
quired for OMV release (6, 8, 33). Supporting this model, deletion
of the peptidoglycan-associated outer membrane proteins OmpA,
Pal, and Lpp has been shown to significantly increase OMV for-
mation in E. coli, S. Typhimurium, and V. cholerae (6, 34–37).
Based on these findings, we predicted that inactivation of pepti-
doglycan-associated outer membrane proteins in P. aeruginosa
would increase OMV formation. To test this hypothesis, OMV
formation of the P. aeruginosa PA14 oprF, oprI, and oprL mutants
was assessed as previously described using a spectrophotometric
lipid assay (31). It is important to note that in strain PA14, oprI is
reported to have a premature stop codon (TAA) at position139
relative to the ATG start codon (64); however, when we sequenced
oprI from P. aeruginosa PA14, it was found that the codon encom-
passing position139 instead encodes glutamic acid (139T¡G),
indicating that the open reading frame is intact. This was con-
firmed by LC-MS/MS data, which showed that OprI is translated
and encodes glutamic acid at amino acid 47.
While the oprI and oprFmutants grew at rates equivalent to the
rate of wild-type (wt) P. aeruginosa (Fig. 1), they produced 3-
fold and8-fold more OMVs, respectively (Fig. 2A). Expression
of oprI and oprF in trans in the corresponding mutants reduced
OMV levels (Fig. 2B), indicating that increased OMV production
was due to the loss of OprF and OprI. The oprL mutant showed a
slight decrease in growth rate and growth yield (Fig. 1), although it
produced OMVs at levels equivalent to those for the wt (Fig. 2A).
While the growth rates of wt P. aeruginosa and the oprF mutant
were equivalent, the oprF mutant reached slightly lower cell yields
(Fig. 1). On the basis of these lower cell yields (OD600 of5 for wt
P. aeruginosa and3.5 for the oprF mutant) and the observation
that P. aeruginosa can undergo autolysis (65), it was possible that
the increase in OMV production in the oprFmutant was due to the
presence of cytoplasmic membrane components (arising from ly-
sis) in our OMV preparations. While we did not think that this was
likely since the growth yield differences were small, it was critical
to examine this possibility experimentally.
If the OMV preparations from the oprF mutant were contam-
inated with cytoplasmic membranes, we reasoned that these prep-
arations would be enriched in cytoplasmic membrane proteins.
To examine this, the proteome of OMV samples from wtP. aerugi-
nosa and the oprF mutant were determined using LC-MS/MS.
Raw files, results, and details of the analyses are available at http:
//www.marcottelab.org/index.php/PSEAE_oprF.2012 and in Ta-
ble S1 in the supplemental material. As was observed by several
FIG 3 OMVs from the P. aeruginosa oprF mutant are not enriched for cytoplasmic membrane proteins. Two biological replicates displaying the proportion of
protein abundance from each cellular compartment in wt P. aeruginosa OMVs and P. aeruginosa oprF mutant OMVs. The protein abundance of each compart-
ment was estimated by dividing the sum of APEX scores of proteins identified in each compartment by the total APEX score for each sample. Protein localization
predictions were obtained from the PseudomonasGenome Database. In wt PA14 samples, 159 (first replicate) and 533 (second replicate) proteins were identified.
In the oprF mutant samples, 504 (first replicate) and 1,140 (second replicate) proteins were identified.
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other groups, OMV preparations in wt P. aeruginosa are enriched
for outer membrane and periplasmic proteins, although some cy-
toplasmic and cytoplasmic membrane proteins are also present.
The relative abundances indicate that the oprFmutant OMV sam-
ple was also enriched for outer membrane proteins and not inner
membrane proteins (Fig. 3), indicating that the increase in OMV
production in the oprF mutant is not due to cell lysis and contam-
ination by cytoplasmic membrane proteins.
Based on work in other bacteria, the increase in OMV levels in
the oprF and oprI mutants was presumably due to detachment of
the outer membrane from the underlying peptidoglycan layer (6,
34–37). However, another possibility is that inactivation of these
proteins altered the levels of PQS, thus leading to increased
OMVs. To test whether production of PQS and its direct precur-
sor, 2-heptyl-4-quinolone (HHQ), were affected in the oprF and
oprI mutants, PQS was measured using TLC and HHQ was mea-
sured using high-performance liquid chromatography (66). The
oprF mutant produced 4-fold more PQS and 1.5-fold more
HHQ than wt P. aeruginosa (Fig. 4A and C), while the oprImutant
produced PQS levels equivalent to those for the wt (Fig. 4A). Im-
portantly, PQS and HHQ production could be genetically com-
plemented by expression of oprF in trans in the oprF mutant (Fig.
4B and C). Recent evidence partially conflicts with these results,
determining that a P. aeruginosa oprF mutant produces lower lev-
els of PQS (67). Our study likely contradicts this study due to the
fact that different quantification methods were used: Fito-Bon-
compte et al. (67) used an LC/MS method (68) to quantify PQS,
and this study used TLC. In contrast to Fito-Boncompte et al., we
and others have found that in the absence of a chelator in the
mobile phase, PQS is difficult to quantify using liquid chromatog-
raphy (66, 69) due to poor peak resolution; thus, TLC provides a
more quantifiable approach.
To determine if the increase in OMV production by the P.
aeruginosa oprFmutant was due to increased PQS production, the
gene (pqsH) encoding the enzyme responsible for the terminal
step in PQS production was deleted in the P. aeruginosa oprF mu-
tant. Since this strain is unable to produce PQS, assessment of
OMV formation by this strain allows the determination of the
importance of PQS for enhanced OMV formation in the oprF
mutant. The P. aeruginosa oprF pqsH double mutant grew simi-
larly to wt P. aeruginosa (Fig. 5A) and produced extremely low
levels of OMVs (Fig. 5B). In fact, OMVs were not detectable in
over half of the OMV preparations. These data support the hy-
pothesis that increased OMV production in the oprF mutant is a
result of increased PQS production. To further test this hypothe-
sis, we examined OMV production by the P. aeruginosa oprF pqsH
double mutant following supplementation with increasing
amounts of PQS (Fig. 5C). OMV production in this strain in-
creased with increasing amounts of PQS (Fig. 5C). Interestingly,
addition of PQS at levels produced by the P. aeruginosa oprF mu-
tant (40 M) resulted in production of very high levels of OMVs
equivalent to those observed in the oprF mutant (Fig. 2A and 5B
and C). In addition, the PQS-induced OMV production by the P.
aeruginosa oprF pqsH double mutant was similar to that observed
upon addition of PQS to the P. aeruginosa pqsH mutant (Fig. 5C).
These data again support a model in which the increase in PQS
production and not simply the lack of OprF is responsible for the
increase in OMV formation by the P. aeruginosa oprF mutant.
The oprI mutant produced more OMVs than the wt; however,
unlike the oprFmutant, it produced wt levels of PQS (Fig. 4A). For
this reason, we hypothesized that the increased OMV production
by the oprI mutant was not due to increased PQS production but
instead was due to loss of peptidoglycan tethering. To test this
hypothesis, we constructed an oprI pqsH double mutant and ex-
amined OMV production in the presence and absence of exoge-
nous PQS. Similar to the pqsH mutant, the oprI pqsH double mu-
tant did not produce detectable levels of OMVs (Fig. 5B);
however, the oprI pqsH double mutant produced 2-fold more
OMVs than the pqsH mutant upon addition of exogenous PQS
(Fig. 5C). These experiments indicate that PQS is necessary for
production of detectable OMVs in the absence of OprI; however,
loss of OprI leads to increased production of OMVs in the pres-
ence of PQS. These data, combined with the fact that OprI is the
only P. aeruginosa outer membrane protein known to covalently
bind to peptidoglycan, suggest that this protein limits PQS-medi-
ated production of OMVs through tethering to peptidoglycan.
This work provides additional insight into the mechanism of
OMV formation in P. aeruginosa. While the absence of the OmpA
homolog OprF increases OMV production, we showed that unlike
other bacterial species, this increase is not directly attributable to
the loss of peptidoglycan binding but instead is attributable to
FIG 4 PQS production by wt P. aeruginosa and the oprL, oprI, and oprF mu-
tants. (A) PQS was extracted from whole cultures and quantified using TLC.
The oprFmutant produces4-fold more PQS than wt. (B) Complementation
of the P. aeruginosa oprF mutant with pEX1.8-oprF restores PQS to wt levels.
(C) The oprF mutant produces slightly more HHQ than the wt, and comple-
mentation of the oprF mutant restores HHQ to wt levels. *, P 	 0.02 via
two-tailed Student’s t test, assuming equal variance (n 4).
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increased production of PQS. As demonstrated for many other
bacterial species (6, 8, 33), deletion of Braun’s lipoprotein ho-
molog oprI resulted in an increase in OMV production most likely
through the loss of the major peptidoglycan-associated lipopro-
tein. Several models, which are not necessarily mutually exclusive,
describe the molecular mechanisms of OMV formation (8, 13,
26–29, 31, 33), but few studies have clarified which models apply
to different species and/or growth conditions. These data have
allowed us to refine the P. aeruginosa bilayer-couple model (31)
for OMV biogenesis through demonstration that OprI reduces
PQS-mediated OMV formation.
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